Compounding Pharmacies
White Label vs. Private Label Supplements: Which Is Right for Your Practice?

The terms are used loosely and often interchangeably, which causes practices to commit to arrangements they have misunderstood. The distinction is real and it turns on one thing: exclusivity.
The Actual Difference
White Label
An existing, finished product — already formulated, tested, and produced — is offered to multiple buyers, each applying their own branding. The same formulation is sold under many different brand names simultaneously.
Advantages: lowest minimums, fastest timeline, no formulation cost, proven product.
Trade-off: no exclusivity. A competing practice may sell an identical product under a different label, and you have no control over the formula.
Private Label
A product is produced for your brand specifically, with some degree of exclusivity over the formulation. This ranges from a modified version of an existing base to a fully custom formulation developed for you.
Advantages: differentiation, formulation control, and — depending on the arrangement — exclusivity.
Trade-off: higher minimums, longer timeline, formulation development cost, and you own the demand risk on a product that does not exist elsewhere.
Where the Confusion Comes From
Many suppliers use "private label" for what is functionally white label — applying your brand to a stock formulation available to anyone. That is not wrong exactly; it is just imprecise, and it matters when you assume exclusivity you do not have.
The question that resolves it: is this formulation exclusive to me, and if so, in what terms — territory, duration, category? A clear answer tells you which model you are actually buying.
Side by Side
| White label | Private label | |
|---|---|---|
| Formulation | Existing, shared across buyers | Custom or modified for you |
| Exclusivity | None | Varies — must be specified |
| Minimum order | Lower | Higher |
| Timeline | Shorter | Longer |
| Development cost | None | Formulation work required |
| Formula control | None | Significant |
| Differentiation | Branding only | Formulation and branding |
| Demand risk | Lower | Higher — you own the SKU |
| Best for | First launch, testing demand | Established demand, clinical differentiation |
Choosing
White Label Fits When
- This is your first branded product and you are testing whether patients buy from you at all
- Capital is limited and you want to avoid tying it up in inventory
- The category is well served by existing formulations and you have no formulation complaint
- You want to launch several SKUs quickly to see which move
- Your differentiation is the clinical relationship, not the formula
Licensed Healthcare Practitioners
6,500+ physician-grade product SKUs, bulk-tier pricing, and direct shipping to your practice. NPI verified, no consumer access.
Private Label Fits When
- You have demonstrated sell-through on a comparable product
- You have a genuine clinical rationale existing formulations do not serve — a dose, combination, or excipient issue you encounter repeatedly
- Differentiation is part of your positioning
- Volume justifies the minimums
- You intend to build a product line rather than sell a few SKUs
The Common Progression
Most practices are best served starting white label, learning what actually sells, then moving specific proven products to private label once demand is established. Starting with custom formulation means guessing at demand while paying the highest minimums — which is how practices end up with expensive inventory they cannot move.
Questions to Ask Any Supplier
- Is this formulation exclusive to me? In what territory, for how long, in what category?
- What are the minimums, and how do they change with volume?
- Who holds the formulation IP if I fund development?
- What testing is performed, and will you provide a certificate of analysis?
- Where is it manufactured, and is the facility cGMP-compliant and third-party audited?
- What is the realistic lead time including testing?
- Who is the responsible party on the label — and therefore who carries liability?
That last question deserves attention. The name and address on the label identifies the responsible party, which has liability implications practices frequently do not consider before their name goes on a bottle.
What Neither Model Changes
Both are dietary supplements, subject to the same rules: structure/function claims permitted with the required disclaimer, disease claims not permitted, Supplement Facts panel in prescribed format. Neither model lets you make claims the other cannot. Our private-label launch walkthrough covers the compliance side.
Neither model covers compounded prescription preparations, which are a separate regulatory category entirely.
Frequently Asked Questions
What is the difference between white label and private label?
White label applies your branding to an existing formulation also sold to other buyers. Private label produces a product for your brand with some degree of formulation exclusivity. The practical difference is exclusivity and formula control.
Which is cheaper?
White label, generally — lower minimums, no formulation development cost, and shorter timelines. Private label costs more up front but allows differentiation.
Can competitors sell the same product as my white label?
Yes. That is the defining characteristic — the same formulation is available to multiple buyers under different brand names.
How do I know if a supplier is offering true private label?
Ask directly whether the formulation is exclusive to you, and in what terms — territory, duration, category. Many suppliers describe stock formulations as private label, which is imprecise and matters if you assume exclusivity you do not have.
Which should I start with?
Most practices are best served starting white label to establish that patients buy branded products from them, then moving proven sellers to private label. Starting with custom formulation means guessing at demand at the highest minimums.
Who is liable for the product?
The name and address on the label identifies the responsible party, which carries liability implications. Clarify this with your supplier before your name goes on a bottle.
More from the blog
Continue reading

Compounding Pharmacy Glossary: 503A, PCAB, USP and More Explained
Plain-language definitions of the terms that matter in compounding — 503A, 503B, PCAB, USP 795/797/800, bulks list, PCAC, BUD, COA, and more.
Oct 16, 2026

Gut Health Peptide Therapy: KPV, Larazotide and BPC-157 Compared
Three peptides studied for gut health, three different mechanisms — cytokine modulation, tight junction regulation, and mucosal angiogenesis — compared.
Oct 14, 2026

Brain Fog and Burnout: Peptide Therapy for Busy Professionals
What actually causes brain fog, why burnout is a distinct condition, what to rule out first, and where cognitive peptides realistically fit.
Oct 12, 2026
For Licensed Providers
